Gold nanoparticles: opportunities and challenges in nanomedicine

被引:428
|
作者
Arvizo, Rochelle [1 ]
Bhattacharya, Resham [1 ]
Mukherjee, Priyabrata [1 ]
机构
[1] Mayo Clin, Ctr Canc, Dept Biochem & Mol Biol, Dept Biomed Engn, Rochester, MN 55905 USA
关键词
biodistribution; cancer; diagnostics; drug delivery; drug targeting; gold nanoparticles; photodynamic therapy; thermal ablation; TARGETED DRUG-DELIVERY; IN-VIVO BIODISTRIBUTION; POLYETHYLENE-GLYCOL; COLLOIDAL GOLD; PARTICLE-SIZE; VASCULAR-PERMEABILITY; TUMOR; THERAPY; RELEASE; BIOLOGY;
D O I
10.1517/17425241003777010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Importance of the field: Site-specific drug delivery is an important area of research that is anticipated to increase the efficacy of the drug and reduce potential side effects. Owing to this, substantial work has been done developing non-invasive and targeted tumor treatment with nanoscale metallic particles. Areas covered in this review: This review focuses on the work done in the last few years developing gold nanoparticles as cancer therapeutics and diagnostic agents. However, there are challenges in using gold nanoparticles as drug delivery systems, such as biodistribution, pharmacokinetics and possible toxicity. Approaches to limit these issues are proposed. What the reader will gain: Different approaches from several different disciplines are discussed. Potential clinical applications of these engineered nanoparticles are also presented. Take home message: As a result of their unique size-dependent physicochemical and optical properties, adaptability, subcellular size and biocompatibility, these nanosized carriers offer a suitable means of transporting small molecules as well as biomacromolecules to diseased cells/tissues.
引用
收藏
页码:753 / 763
页数:11
相关论文
共 50 条
  • [11] Cancer nanomedicine: progress, challenges and opportunities
    Shi, Jinjun
    Kantoff, Philip W.
    Wooster, Richard
    Farokhzad, Omid C.
    NATURE REVIEWS CANCER, 2017, 17 (01) : 20 - 37
  • [12] Managing diabetes with nanomedicine: challenges and opportunities
    Veiseh, Omid
    Tang, Benjamin C.
    Whitehead, Kathryn A.
    Anderson, Daniel G.
    Langer, Robert
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (01) : 45 - 57
  • [13] Emerging nanomedicine opportunities with perfluorocarbon nanoparticles
    Winter, Patrick M.
    Cai, Kejia
    Caruthers, Shelton D.
    Wickline, Samuel A.
    Lanza, Gregory M.
    EXPERT REVIEW OF MEDICAL DEVICES, 2007, 4 (02) : 137 - 145
  • [14] Gold nanoparticles: From nanomedicine to nanosensing
    Chen, Po C.
    Mwakwari, Sandra C.
    Oyelere, Adegboyega K.
    NANOTECHNOLOGY SCIENCE AND APPLICATIONS, 2008, 1 : 45 - 65
  • [15] Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities
    Mohamed, Nourhan K.
    Hamad, Mostafa A.
    Hafez, Mohamed Z. E.
    Wooley, Karen L.
    Elsabahy, Mahmoud
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (07) : 1475 - 1484
  • [16] Nanomedicine in Healing Chronic Wounds: Opportunities and Challenges
    Sharifi, Shahriar
    Hajipour, Mohammad Javad
    Gould, Lisa
    Mahmoudi, Morteza
    MOLECULAR PHARMACEUTICS, 2021, 18 (02) : 550 - 575
  • [17] Cancer nanomedicine meets immunotherapy: opportunities and challenges
    Qingxue Sun
    Xiangyang Bai
    Alexandros Marios Sofias
    Roy van der Meel
    Eduardo Ruiz-Hernandez
    Gert Storm
    Wim E. Hennink
    Bruno De Geest
    Fabian Kiessling
    Hai-jun Yu
    Twan Lammers
    Yang Shi
    Acta Pharmacologica Sinica, 2020, 41 : 954 - 958
  • [18] Vascular Nanomedicine: Current Status, Opportunities, and Challenges
    Sun, Michael
    Sen Gupta, Anirban
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2020, 46 (05): : 524 - 544
  • [19] Graphene: Promises, Facts, Opportunities, and Challenges in Nanomedicine
    Mao, Hong Ying
    Laurent, Sophie
    Chen, Wei
    Akhavan, Omid
    Imani, Mohammad
    Ashkarran, Ali Akbar
    Mahmoudi, Morteza
    CHEMICAL REVIEWS, 2013, 113 (05) : 3407 - 3424
  • [20] Cancer nanomedicine meets immunotherapy: opportunities and challenges
    Sun, Qingxue
    Bai, Xiangyang
    Sofias, Alexandros Marios
    van der Meel, Roy
    Ruiz-Hernandez, Eduardo
    Storm, Gert
    Hennink, Wim E.
    De Geest, Bruno
    Kiessling, Fabian
    Yu, Hai-jun
    Lammers, Twan
    Shi, Yang
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (07) : 954 - 958